About vildaglipti n
DPP-4 inhibitor plus biguanide
Used for
- Type 2 diabetes, alongside diet and exercise.
- Improves blood sugar when other diabetes medicines are insufficient.
Usual adult dose
Usually one tablet twice daily with meals; the dose depends on previous treatment and kidney function.
Common side effects
- Nausea, diarrhoea, or abdominal discomfort.
- Headache or dizziness.
- Low blood sugar, especially with insulin or sulfonylureas.
- Rarely, liver problems or pancreatitis.
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Avoid in severe kidney problems; kidney function should be checked.
- Seek urgent care for severe, persistent abdominal pain or signs of liver problems.
- Metformin may rarely cause serious lactic acidosis, especially with kidney, liver, or severe heart problems.
Pregnancy
Not usually recommended; metformin-containing treatment may be considered only under clinician supervision.
Breastfeeding
Generally not recommended because of limited information and possible effects on the infant.
Interactions
- Alcohol increases the risk of metformin-related lactic acidosis.
- Insulin or sulfonylureas increase low blood sugar risk.
- Some medicines, including cimetidine and certain diuretics, can affect metformin levels or kidney function.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.